Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Suzuken CoTSE:9987 +3.28%79 Buyback Yield % is 7.45 as of Jul. 16, 2026, which is 136% above its 10-year median of 3.16. GuruFocus rates TSE:9987 with a GF Score™ of 79/100 and a GF Value™ of 円5,918.83 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 39 Medical Distribution companies, Suzuken Co ranks better than 89.74% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Suzuken Co's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9987 vs MCK, CAH, COR: Buyback Yield % Comparison
For the Medical Distribution subindustry, Suzuken Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Suzuken Co Buyback Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Suzuken Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Suzuken Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzuken Co (TSE:9987) has a Buyback Yield % of 7.45 as of Jul. 16, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Suzuken Co and its competitors. This is 136% above median its historical median of 3.16. Over the past decade, Suzuken Co's Buyback Yield % has ranged from 0.02 to 7.86. According to the industry distribution chart, Suzuken Co ranks #4 out of 39 companies in the Medical Distribution industry, placing it in the top 10.3%.
Is Suzuken Co's Buyback Yield % too high?
Suzuken Co's current Buyback Yield % of 7.45 is 136% above median its 10-year median of 3.16. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 7.86. The Medical Distribution industry median Buyback Yield % is 0.05. Suzuken Co's value of 7.45 is 14800% above this industry median. Based on the distribution chart, Suzuken Co ranks #4 out of 39 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Suzuken Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Suzuken Co's Buyback Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Suzuken Co ranks #4 out of 39 companies for Buyback Yield %. This places Suzuken Co in the top 10% of its industry — outperforming the majority of peers. The industry median Buyback Yield % is 0.05. Suzuken Co's value of 7.45 is 14800% above this benchmark. Historically, Suzuken Co's own Buyback Yield % has ranged from 0.02 to 7.86 over the past decade. While the company's 10-year median is 3.16 vs. the industry median of 0.05, Suzuken Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Distribution company?
The median Buyback Yield % among Medical Distribution companies is 0.05, based on 39 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Suzuken Co's current Buyback Yield % of 7.45 is 14800% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Suzuken Co and its competitors. For the Medical Distribution industry, the median Buyback Yield % is 0.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzuken Co's current Buyback Yield % is 7.45, which is 136% above median its own 10-year median of 3.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzuken Co stock overvalued right now?
Based on GuruFocus' analysis, Suzuken Co (TSE:9987) is currently considered Modestly Undervalued. The stock's GF Value™ is 円5,918.83, compared to a current price of 円5,157.00 — trading 12.9% below its estimated fair value. The current Buyback Yield % is 7.45, which is 136% above median its 10-year median of 3.16 and 14800% above the Medical Distribution industry median of 0.05. Suzuken Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Suzuken Co (TSE:9987), the current Buyback Yield % is 7.45 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Suzuken Co (TSE:9987) Overvalued in 2026?
Based on GuruFocus' analysis, Suzuken Co stock appears to be undervalued.
The current stock price of 円5,157.00 is trading 12.9% below its estimated GF Value™ of 円5,918.83.
GuruFocus considers Suzuken Co to be Modestly Undervalued.
Key valuation signals for TSE:9987:
Buyback Yield %: 7.45 (136% above median its 10-year median of 3.16)
GF Value™: 円5,918.83 vs. price of 円5,157.00 (12.9% below fair value)
Industry Position: 14800% above the Medical Distribution median (#4 of 39)
No single metric tells the full story. See the TSE:9987 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Suzuken Co Ltd is engaged in the manufacture and sale of pharmaceuticals and medical devices, and in providing insurance, pharmacy, and nursing care services. The company operates through segments, including Pharmaceutical Wholesale business, Healthcare product development business, Specialty Pharmaceuticals Distribution business, Regional medical nursing care support business, and Medical-related Services business. It generates the majority of its revenue from the Pharmaceutical Wholesale Business segment, which sells prescription pharmaceuticals, diagnostic reagents, medical equipment, and medical supplies.
79GF Score
Get the complete analysis for TSE:9987
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9987 has been successfully added to your 
